Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Enterprise Value: 241.66M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 241.66M |
| November 21, 2024 | 252.13M |
| November 20, 2024 | 249.52M |
| November 19, 2024 | 246.52M |
| November 18, 2024 | 248.39M |
| November 15, 2024 | 249.89M |
| November 14, 2024 | 257.74M |
| November 13, 2024 | 264.10M |
| November 12, 2024 | 271.58M |
| November 11, 2024 | 283.91M |
| November 08, 2024 | 297.37M |
| November 07, 2024 | 302.98M |
| November 06, 2024 | 316.44M |
| November 05, 2024 | 314.57M |
| November 04, 2024 | 295.50M |
| November 01, 2024 | 299.62M |
| October 31, 2024 | 294.01M |
| October 30, 2024 | 301.28M |
| October 29, 2024 | 296.25M |
| October 28, 2024 | 306.72M |
| October 25, 2024 | 305.23M |
| October 24, 2024 | 300.74M |
| October 23, 2024 | 301.11M |
| October 22, 2024 | 304.10M |
| October 21, 2024 | 297.75M |
| Date | Value |
|---|---|
| October 18, 2024 | 298.87M |
| October 17, 2024 | 299.62M |
| October 16, 2024 | 297.75M |
| October 15, 2024 | 297.75M |
| October 14, 2024 | 297.75M |
| October 11, 2024 | 301.49M |
| October 10, 2024 | 299.99M |
| October 09, 2024 | 298.12M |
| October 08, 2024 | 291.77M |
| October 07, 2024 | 290.27M |
| October 04, 2024 | 255.15M |
| October 03, 2024 | 253.08M |
| October 02, 2024 | 260.65M |
| October 01, 2024 | 259.79M |
| September 30, 2024 | 270.97M |
| September 27, 2024 | 260.05M |
| September 26, 2024 | 242.34M |
| September 25, 2024 | 221.06M |
| September 24, 2024 | 215.90M |
| September 23, 2024 | 219.68M |
| September 20, 2024 | 216.24M |
| September 19, 2024 | 222.43M |
| September 18, 2024 | 213.49M |
| September 17, 2024 | 212.75M |
| September 16, 2024 | 213.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.20M
Minimum
Dec 05 2022
857.31M
Maximum
Aug 06 2021
253.34M
Average
209.37M
Median
Aug 12 2024
Enterprise Value Benchmarks
| Galapagos NV | -1.941B |
| UCB SA | 37.88B |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | 95.14M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.76M |
| Revenue (Quarterly) | 1.392M |
| Total Expenses (Quarterly) | 17.87M |
| EPS Diluted (Quarterly) | -0.5455 |
| Gross Profit Margin (Quarterly) | 61.93% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -23.32% |
| Normalized Earnings Yield | -22.45 |